These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30599154)

  • 21. Human α-synuclein overexpression in a mouse model of Parkinson's disease leads to vascular pathology, blood brain barrier leakage and pericyte activation.
    Elabi O; Gaceb A; Carlsson R; Padel T; Soylu-Kucharz R; Cortijo I; Li W; Li JY; Paul G
    Sci Rep; 2021 Jan; 11(1):1120. PubMed ID: 33441868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models.
    Hebron ML; Lonskaya I; Moussa CE
    Hum Mol Genet; 2013 Aug; 22(16):3315-28. PubMed ID: 23666528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Running wheel exercise reduces α-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease.
    Zhou W; Barkow JC; Freed CR
    PLoS One; 2017; 12(12):e0190160. PubMed ID: 29272304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra.
    St Martin JL; Klucken J; Outeiro TF; Nguyen P; Keller-McGandy C; Cantuti-Castelvetri I; Grammatopoulos TN; Standaert DG; Hyman BT; McLean PJ
    J Neurochem; 2007 Mar; 100(6):1449-57. PubMed ID: 17241127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective effect of treadmill exercise possibly via regulation of lysosomal degradation molecules in mice with pharmacologically induced Parkinson's disease.
    Hwang DJ; Koo JH; Kwon KC; Choi DH; Shin SD; Jeong JH; Um HS; Cho JY
    J Physiol Sci; 2018 Sep; 68(5):707-716. PubMed ID: 29260454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice.
    Rabl R; Breitschaedel C; Flunkert S; Duller S; Amschl D; Neddens J; Niederkofler V; Rockenstein E; Masliah E; Roemer H; Hutter-Paier B
    BMC Neurosci; 2017 Jan; 18(1):22. PubMed ID: 28143405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson's disease mice.
    Jang Y; Koo JH; Kwon I; Kang EB; Um HS; Soya H; Lee Y; Cho JY
    Brain Res; 2017 Jan; 1655():186-193. PubMed ID: 27816415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of Macroautophagy in Dopamine Neurons Has Opposing Effects on Parkinsonian Pathology and Behavior.
    Hunn BHM; Vingill S; Threlfell S; Alegre-Abarrategui J; Magdelyns M; Deltheil T; Bengoa-Vergniory N; Oliver PL; Cioroch M; Doig NM; Bannerman DM; Cragg SJ; Wade-Martins R
    Cell Rep; 2019 Oct; 29(4):920-931.e7. PubMed ID: 31644913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative Analysis of MPTP Neurotoxicity in Mice with a Constitutive Knockout of the α-Synuclein Gene].
    Chaprov KD; Teterina EV; Roman AY; Ivanova TA; Goloborshcheva VV; Kucheryanu VG; Morozov SG; Lysikova EA; Lytkina OA; Koroleva IV; Popova NI; Antohin AI; Ovchinnikov RK; Kukharsky MS
    Mol Biol (Mosk); 2021; 55(1):152-163. PubMed ID: 33566034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function.
    Oaks AW; Frankfurt M; Finkelstein DI; Sidhu A
    PLoS One; 2013; 8(4):e60378. PubMed ID: 23560093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motor deficits and beta oscillations are dissociable in an alpha-synuclein model of Parkinson's disease.
    Brys I; Nunes J; Fuentes R
    Eur J Neurosci; 2017 Aug; 46(3):1906-1917. PubMed ID: 28370471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
    Hansen C; Björklund T; Petit GH; Lundblad M; Murmu RP; Brundin P; Li JY
    Neurobiol Dis; 2013 Aug; 56():145-55. PubMed ID: 23643841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.
    Kishimoto Y; Zhu W; Hosoda W; Sen JM; Mattson MP
    Neuromolecular Med; 2019 Sep; 21(3):239-249. PubMed ID: 31079293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
    Phan JA; Stokholm K; Zareba-Paslawska J; Jakobsen S; Vang K; Gjedde A; Landau AM; Romero-Ramos M
    Sci Rep; 2017 Jul; 7(1):6363. PubMed ID: 28743955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
    Gu PS; Moon M; Choi JG; Oh MS
    J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
    Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG; Bensadoun JC; Aebischer P; Schneider BL
    J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine and α-synuclein dysfunction in Smad3 null mice.
    Tapia-González S; Giráldez-Pérez RM; Cuartero MI; Casarejos MJ; Mena MÁ; Wang XF; Sánchez-Capelo A
    Mol Neurodegener; 2011 Oct; 6():72. PubMed ID: 21995845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
    Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
    Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treadmill exercise reduces α-synuclein spreading via PPARα.
    Dutta D; Paidi RK; Raha S; Roy A; Chandra S; Pahan K
    Cell Rep; 2022 Jul; 40(2):111058. PubMed ID: 35830804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.